RISI, MARIO
 Distribuzione geografica
Continente #
EU - Europa 42
NA - Nord America 12
AS - Asia 10
Totale 64
Nazione #
IT - Italia 21
IE - Irlanda 14
US - Stati Uniti d'America 12
SG - Singapore 6
GB - Regno Unito 2
IR - Iran 2
NL - Olanda 2
CN - Cina 1
DE - Germania 1
FI - Finlandia 1
PK - Pakistan 1
SE - Svezia 1
Totale 64
Città #
Dublin 14
Naples 10
Singapore 5
Amsterdam 2
Aversa 2
Cercola 2
New York 2
Trecase 2
Beijing 1
Boston 1
Bremen 1
Cambridge 1
Chandler 1
Kamoke 1
Lappeenranta 1
Miami 1
Milan 1
Napoli 1
Princeton 1
Redwood City 1
Roxbury 1
Turin 1
Totale 53
Nome #
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 36
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 12
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 11
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study 7
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey 4
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 3
Totale 73
Categoria #
all - tutte 563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 1 2 4 0 0 0 0 1 0 3
2022/202320 2 0 1 0 1 1 0 1 10 0 2 2
2023/202439 0 0 4 0 3 2 0 1 14 2 8 5
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 73